Authors:
Van Aken, H
Bode, C
Darius, H
Diehm, C
Encke, M
Gulba, DC
Haas, S
Hacke, W
Puhl, W
Quante, M
Riess, H
Scharf, R
Schellong, S
Schror, K
Schulte, KL
Tebbe, U
Citation: H. Van Aken et al., Anticoagulation: The present and future, CL APPL T-H, 7(3), 2001, pp. 195-204
Authors:
Siegert, G
Schellong, S
Knoefler, R
Jaross, W
Citation: G. Siegert et al., Low molecular weight heparin: a possible cause for higher protein S activity than free protein S concentration, BL COAG FIB, 11(8), 2000, pp. 747-754
Authors:
Siegert, G
Kostka, H
Gehrisch, S
Schwarz, T
Schellong, S
Jaross, W
Citation: G. Siegert et al., Method-dependent influence of certain polymorphisms in the factor VB-domain on the response to activated protein C, BL COAG FIB, 11(6), 2000, pp. 519-527
Authors:
Kostka, H
Siegert, G
Schwarz, T
Gehrisch, S
Kuhlisch, E
Schellong, S
Jaross, W
Citation: H. Kostka et al., Frequency of polymorphisms in the B-domain of factor V gene in APC-resistant patients, THROMB RES, 99(6), 2000, pp. 539-547
Authors:
Garlichs, CD
Beyer, J
Zhang, H
Schmeisser, A
Plotze, K
Mugge, A
Schellong, S
Daniel, WG
Citation: Cd. Garlichs et al., Decreased plasma concentrations of L-hydroxyarginine as a marker of reduced NO formation in patients with combined cardiovascular risk factors, J LA CL MED, 135(5), 2000, pp. 419-425
Authors:
Werner, D
Schellong, S
Weise, M
Klinghammer, L
Nolte, C
Daniel, WG
Citation: D. Werner et al., Transesophageal demonstration of a coronary fistula with associated infective endocarditis, Z KARDIOL, 88(3), 1999, pp. 229-232